Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS

Journal of NeuroVirology

Volumn 17, Issue 5, 2011, Pages 500-503

  McGuire, Jennifer L ^a,b   Fridman, Vera ^c   Wüthrich, Christian ^d   Koralnik, Igor J ^d   Jacobs, Dina ^e  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEFLOQUINE; METHYLPREDNISOLONE; MIRTAZAPINE; MYELIN BASIC PROTEIN; OLIGOCLONAL BAND; STEROID;

ADD ON THERAPY; ADULT; ARTICLE; BEDTIME DOSAGE; BRAIN BIOPSY; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; THOUGHT DISORDER; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOPENIA; MAGNETIC RESONANCE IMAGING; MEFLOQUINE; MIANSERIN; MULTIPLE SCLEROSIS; NEUROIMAGING; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 84856148133     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0045-2     Document Type: Article

References (23)

1. Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998a) Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44(3):341-349 (Pubitemid 28421438)
2. Berger JR, Pall L, Lanska D, Whiteman M (1998b) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4(1):59-68 (Pubitemid 28081579)
3. Boerman R, Bax J, Beekhuis-Brussee J, Medaer R, Bollen L (1993) JC virus and multiple sclerosis: a refutation? Acta Neurol Scand 87:353-355 (Pubitemid 23171047)
4. Boothpur R, Brennan DC (2010) Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 47(4):306-312
5. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K et al (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53(5):1840-1849
6. Cettomai D, McArthur JC (2009) Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 66(2):255-258
7. Du Pasquier RA, Autissier P, Zheng Y, Jean-Jacques J, Koralnik IJ (2005) Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS 19(18):2069-2076 (Pubitemid 41668994)
8. Epker JL, van Biezen P, van Daele PLA, van Gelder T, Vossen A, van Saase JLCM (2009) Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Inter Med 20(3):261-267
9. Ferrante P, Omodeo-Zorini E, Caldarelli-Stefano R, Mediatai M, Fainardi E, Granieri E et al (1998) Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 4:49-54 (Pubitemid 28197346)
10. Friedman R (2011) Malaria drug fails to fulfill promise in PML. Neurology Today 11(8):8
11. Gergely P (1999) Drug-induced lymphopenia: focus on CD4+ and CD8+ cells. Drug Saf 21(2):91-100 (Pubitemid 29389170)
12. Gheuens S, Bord E (2011) Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85(14):2506-2510
13. Gheuens S, Pierone G, Peeters P, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatr 81(3):247-254
14. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA (2011) Surgery induced immunosuppression. Surgeon 9(1):38-43
15. Koralnik IJ (2004) New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 17(3):365-370 (Pubitemid 38720991)
16. Koralnik IJ (2006) Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60(2):162-173 (Pubitemid 44182391)
17. Narula S, Larosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98(5):483-489 (Pubitemid 46752643)
18. Nishimura T, Kamikura I, Kamei S, Takasu T, Sugawara T, Hirayama H (1993) A unilateral large demyelinating lesion in the cerebral white matter with slowly progressive hemiplegia and intrathecal JC virus antibody production. Rinsho Shinkeigaku 33(3):301-306 (Pubitemid 23271688)
19. Sabath BF, Major EO (2002) Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis 186(Suppl 2):S180-S186 (Pubitemid 35370479)
20. Stoner G (1991) Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS. Acta Neurol Scand 83:20-33
21. Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9(4):425-437
22. Vermersch P, Kappos L, Gold R, Foley JF, Olsson T, Cadavid D et al (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 76(20):1697-1704
23. Weber T (2008) Progressive multifocal leukoencephalopathy. Neurol Clin 26(3):833-854, x-xi (Pubitemid 352020489)